OSCR Classe A Oscar Health, Inc. Class A Common Stock
NYSE · Insurance · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 7, 2026OSCR Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
OSCR Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre Oscar Health, Inc. Class A Common Stock Visão geral da empresa da Wikipedia
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
History
2012–2015
According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Kushner and his brother, Jared, owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.
2016
Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".
In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."
2017
On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.
On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.
A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Kushner's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.
While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.
2020–present
In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."
As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."
Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.
Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.
Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO.
In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.
Marketing and brand
Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".
In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.
In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.
Finances
Funding
Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.
During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.
During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.
In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.
During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.
In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.
Revenue
In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.
Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."
By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.
In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.
In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.
In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.
In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.
Headquarters and offices
Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | OSCR | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 21.3média 5A ≈23.0 | ≈23.0 | 15.4 | Sobreavaliado |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | OSCR | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 4.1%média 5A ≈-9.1% | ≈-9.1% | 10.1% | Fraco | |
| Margem EBITDA (TTM) | 4.3%média 5A ≈-8.6% | ≈-8.6% | 8.2% | Em linha | |
| Margem de Impostos Pré-Tributação (TTM) | 3.9%média 5A ≈-9.7% | ≈-9.7% | 17.3% | Fraco | |
| Margem de Lucro Líquido (TTM) | 3.6%média 5A ≈-9.8% | ≈-9.8% | 10.3% | Fraco | |
| ROA (TTM) | 6.3%média 5A ≈-8.6% | ≈-8.6% | 0.54% | Fraco | |
| ROE (TTM) | 34.3%média 5A ≈-27.6% | ≈-27.6% | 12.2% | Fraco | |
| ROIC | -28.5%média 5A ≈-21.5% | ≈-21.5% | 15.6% | Fraco |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | OSCR | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 0.2média 5A ≈0.3 | ≈0.3 | 0.0 | Dívida alta | |
| Índice de liquidez corrente (MRQ) | 1.1média 5A ≈1.1 | ≈1.1 | · | · | |
| Quick Ratio (Índice de Liquidez Seca) | 0.6média 5A ≈0.6 | ≈0.6 | · | · | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 0.2média 5A ≈0.3 | ≈0.3 | · | · |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | OSCR | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 27.5%média 5A ≈109.0% | ≈109.0% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 43.5%média 5A ≈82.5% | ≈82.5% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 90.8% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | OSCR | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 2.1média 5A ≈1.6 | ≈1.6 | 0.1 | Primeira linha | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$5.1M | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 6, 2026 | $1.10 | $0.39 | 179.5% |
| 31 de Março de 2026 | $2.07 | $1.21 | 71.5% | |
| 31 de Dezembro de 2025 | $-1.24 | $-0.91 | -37.0% | |
| 30 de Setembro de 2025 | $-0.53 | $-0.57 | 6.6% | |
| 30 de Junho de 2025 | $-0.89 | $-0.47 | -88.5% | |
| 31 de Março de 2025 | $0.92 | $0.81 | 13.8% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $463M | |
| SG&A Expense | $2.05B | $1.76B | $1.43B | $1.26B | $265M | $167M | |
| Operating Income | $-396M | $57M | $-236M | $-590M | $-544M | $-402M | |
| Interest Expense | · | · | $25M | $23M | $5M | $4M | |
| Other Non-op | $-23M | $-105.0K | $-7M | $2M | $-1M | · | |
| Pretax Income | $-437M | $33M | $-267M | $-610M | $-571M | $-406M | |
| Income Tax | $6M | $7M | $3M | $-523.0K | $846.0K | $1M | |
| Net Income | $-443M | $25M | $-271M | $-606M | $-573M | $-407M | |
| EPS (Basic) | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| EPS (Diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| Shares (Basic) | 262,388,000 | 240,386,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| Shares (Diluted) | 262,388,000 | 265,853,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| EBITDA | $-367M | $89M | $-205M | · | $-530M | · |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826M | |
| Short-term Investments | · | $624M | $690M | · | · | · | |
| Receivables | $363M | · | · | · | · | · | |
| Other Current Assets | $24M | $21M | $7M | $6M | $4M | · | |
| Current Assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B | |
| PP&E (Net) | $88M | $67M | $62M | $60M | $47M | $36M | |
| PP&E (Gross) | $230M | $181M | $150M | $117M | $89M | $63M | |
| Accum. Depreciation | $142M | $114M | $88M | $57M | $42M | $27M | |
| Other Non-current Assets | $120M | $82M | $83M | $95M | $97M | $13M | |
| Total Assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | |
| Accounts Payable | $507M | $432M | $273M | $298M | $235M | $138M | |
| Current Liabilities | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B | $1.67B | |
| Capital Leases | $52M | $61M | $67M | $72M | $77M | · | |
| Other Non-current Liabilities | $52M | $61M | $68M | $72M | $77M | $0 | |
| Total Liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B | |
| Total Debt | $430M | $300M | $299M | · | $0 | · | |
| Common Stock | · | · | · | · | · | $2.0K | |
| Paid-in Capital | $4.26B | $3.87B | $3.68B | $3.51B | $3.39B | $133M | |
| Retained Earnings | $-3.29B | $-2.85B | $-2.88B | $-2.61B | $-2.00B | $-1.43B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | |
| AOCI | $18M | $-2M | $1M | $-10M | $-4M | $879.0K | |
| Stockholders' Equity | $978M | $1.01B | $804M | $890M | $1.39B | $-1.30B | |
| Liabilities + Equity | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $29M | $32M | $31M | $15M | $15M | $11M | |
| Stock-based Comp | $88M | $110M | $160M | $112M | $86M | $36M | |
| Deferred Tax | $2M | $-2M | $58.0K | $-165.0K | $-101.0K | $-67.0K | |
| Other Non-cash | $1.42B | $813M | $-192M | · | $290M | · | |
| Operating Cash Flow | $1.09B | $978M | $-272M | $380M | $-182M | $223M | |
| CapEx | $36M | $28M | $26M | $29M | $26M | $14M | |
| Investing Cash Flow | $-241M | $-1.39B | $577M | $-227M | $-775M | $-345M | |
| Debt Issued | $410M | $0 | $0 | $305M | $0 | $147M | |
| Net Debt Issued | $410M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $399M | $68M | $6M | $301M | $1.24B | $612M | |
| Net Change in Cash | $1.25B | $-341M | $311M | $455M | $282M | $490M | |
| Taxes Paid | $18M | $674.0K | $2M | $2M | $697.0K | $2M | |
| Free Cash Flow | $1.06B | $950M | $-298M | · | $-208M | · | |
| Levered FCF | · | · | $-323M | · | $-212M | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.4% | 0.62% | -4.0% | · | -29.6% | · | |
| Net Margin | -3.8% | 0.28% | -4.6% | · | -31.1% | · | |
| Pretax Margin | -3.7% | 0.36% | -4.6% | · | -31.0% | · | |
| EBITDA Margin | -3.1% | 0.97% | -3.5% | · | -28.8% | · | |
| ROA | -7.9% | 0.60% | -6.7% | · | -20.5% | · | |
| ROE | -44.5% | 2.8% | -32.0% | · | -36.7% | · | |
| ROIC | -28.5% | 3.4% | -21.6% | · | -39.3% | · |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.8 | 1.3 | · | 1.2 | · | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | · | 0.6 | · | |
| Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| LT Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| Interest Coverage | · | · | -9.6 | · | -115.4 | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.1 | 2.2 | 1.4 | · | 0.7 | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $44.60 | $34.52 | $26.45 | · | $10.27 | · | |
| Cash Flow / Share | $4.17 | $3.68 | $-1.23 | · | $-1.02 | · | |
| EPS (TTM) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 27.5% | 56.5% | 47.9% | 115.6% | 297.3% | · | |
| Revenue CAGR 3Y | 43.5% | 70.9% | 133.1% | · | · | · | |
| Revenue CAGR 5Y | 90.8% | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | · | |
| Net Income TTM | $-443M | $25M | $-271M | $-606M | $-573M | · | |
| P/E | -8.5 | 134.4 | -7.5 | -0.9 | -2.5 | · | |
| Earnings Yield | -11.8% | 0.74% | -13.3% | -115.9% | -40.8% | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B | $2.22B | $2.14B | $1.43B | $1.44B | $1.52B | $1.47B | $995M | $978M | |
| SG&A Expense | $691M | $706M | $511M | $522M | $534M | $483M | $466M | $460M | $435M | $394M | $364M | $326M | $337M | $399M | $1.02B | $79M | |
| Operating Income | $389M | $704M | $-334M | $-129M | $-230M | $297M | $-148M | $-48M | $68M | $186M | $-145M | $-58M | $-7M | $-25M | $-222M | $-192M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | |
| Other Non-op | $-915.0K | $71.0K | $-20M | $-3M | $3M | $-3M | $68.0K | $2M | $-872.0K | $-1M | $1M | $-414.0K | $-2M | $-6M | $1M | $3M | |
| Pretax Income | $383M | $699M | $-353M | $-139M | $-234M | $288M | $-154M | $-52M | $61M | $178M | $-151M | $-65M | $-14M | $-38M | $-227M | $-195M | |
| Income Tax | $21M | $20M | $-247.0K | $-2M | $-5M | $13M | $-404.0K | $2M | $5M | $996.0K | $-806.0K | $915.0K | $1M | $2M | $-715.0K | $-2M | |
| Net Income | $362M | $679M | $-353M | $-137M | $-228M | $275M | $-154M | $-55M | $56M | $177M | $-150M | $-65M | $-16M | $-40M | $-226M | $-193M | |
| EPS (Basic) | $1.20 | $2.28 | $-1.37 | $-0.53 | $-0.89 | $1.10 | $-0.68 | $-0.22 | $0.24 | $0.77 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| EPS (Diluted) | $1.10 | $2.07 | $-1.19 | $-0.53 | $-0.89 | $0.92 | $-0.50 | $-0.22 | $0.20 | $0.62 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| Shares (Basic) | 302,220,000 | 298,184,000 | · | 259,273,000 | 255,531,000 | 251,279,000 | · | 243,106,000 | 238,672,000 | 231,443,000 | · | 223,099,000 | 219,400,000 | 216,913,000 | · | 212,822,733 | |
| Shares (Diluted) | 333,432,000 | 329,751,000 | · | 259,273,000 | 255,531,000 | 305,938,000 | · | 243,106,000 | 303,965,000 | 293,796,000 | · | 223,099,000 | 219,400,000 | 216,913,000 | · | 212,822,733 | |
| EBITDA | $389M | $711M | · | $-129M | $-230M | $304M | · | $-48M | $68M | $193M | · | $-58M | $-7M | $-20M | · | $-192M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B | $2.27B | $2.23B | $1.87B | $1.40B | $2.32B | $2.11B | $1.56B | $2.11B | |
| Receivables | $380M | $587M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $60M | $26M | $24M | $29M | $30M | $23M | $21M | $21M | $16M | $9M | · | $8M | $8M | $11M | · | $16M | |
| Current Assets | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B | $2.37B | $3.36B | $3.50B | · | $2.99B | $4.19B | $4.13B | · | $3.93B | |
| PP&E (Net) | $101M | $94M | $88M | $83M | $78M | $72M | $67M | $67M | $64M | $61M | · | $62M | $63M | $64M | · | $56M | |
| PP&E (Gross) | · | · | $230M | · | · | · | $181M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $142M | · | · | · | $114M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $122M | $123M | $120M | $121M | $116M | $94M | $82M | $84M | $87M | $87M | · | $89M | $92M | $95M | · | $97M | |
| Total Assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B | |
| Accounts Payable | $526M | $506M | $650M | $557M | $584M | $634M | $432M | $395M | $348M | $303M | · | $260M | $262M | $299M | · | $252M | |
| Current Liabilities | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B | $2.95B | $3.50B | $3.02B | · | $2.06B | $3.24B | $3.18B | · | $2.85B | |
| Capital Leases | · | · | $52M | · | · | · | $61M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $50M | $51M | $52M | $56M | $57M | $59M | $61M | $64M | $65M | $66M | · | $69M | $70M | $71M | · | $74M | |
| Total Liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B | $3.87B | $3.38B | · | $2.43B | $3.61B | $3.55B | · | $3.22B | |
| Total Debt | $432M | $431M | · | $686M | $300M | $300M | · | $299M | $299M | $299M | · | $299M | $298M | $298M | · | $298M | |
| Paid-in Capital | $4.32B | $4.28B | $4.26B | $3.95B | $3.95B | $3.90B | $3.87B | $3.84B | $3.79B | $3.74B | · | $3.65B | $3.62B | $3.58B | · | $3.48B | |
| Retained Earnings | $-2.25B | $-2.62B | $-3.29B | $-2.94B | $-2.80B | $-2.58B | $-2.85B | $-2.70B | $-2.64B | $-2.70B | · | $-2.73B | $-2.66B | $-2.65B | · | $-2.38B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| AOCI | $-8M | $5M | $18M | $16M | $14M | $10M | $-2M | $26M | $-3M | $-3M | · | $-4M | $-7M | $-4M | · | $-14M | |
| Stockholders' Equity | $2.05B | $1.66B | $978M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | · | $919M | $950M | $930M | · | $1.08B | |
| Liabilities + Equity | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $7M | $8M | $7M | $7M | $7M | $9M | $8M | $8M | $8M | $8M | $9M | $9M | $5M | $4M | $4M | |
| Stock-based Comp | $21M | $16M | $18M | $20M | $24M | $25M | $26M | $29M | $29M | $26M | $26M | $29M | $33M | $71M | $29M | $29M | |
| Deferred Tax | $-2M | $-6M | $3M | $-175.0K | $-36.0K | $36.0K | $-2M | $-119.0K | $130.0K | $-79.0K | $-37.0K | $69.0K | $209.0K | $-183.0K | $-171.0K | $2.0K | |
| Other Non-cash | · | $1.92B | · | · | · | $572M | · | · | · | $423M | · | · | · | $378M | · | · | |
| Operating Cash Flow | $2.09B | $2.62B | $672M | $-965M | $509M | $879M | $347M | $-500M | $497M | $634M | $297M | $-1.15B | $166M | $415M | $151M | $-548M | |
| CapEx | $12M | $9M | $9M | $9M | $9M | $9M | $7M | $8M | $8M | $6M | $6M | $6M | $6M | $7M | $7M | $10M | |
| Investing Cash Flow | $-2.83B | $-590M | $-49M | $150M | $-168M | $-174M | $-31M | $-578M | $-478M | $-301M | $172M | $225M | $44M | $136M | $-707M | $299M | |
| Debt Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $13M | $-4M | $8M | $364M | $22M | $5M | $4M | $19M | $19M | $27M | $1M | $2M | $3M | $506.0K | $527.0K | $423.0K | |
| Net Change in Cash | $-729M | $2.03B | $631M | $-451M | $363M | $709M | $319M | $-1.06B | $38M | $361M | $470M | $-922M | $212M | $551M | $-555M | $-249M | |
| Taxes Paid | $1M | $44.0K | $19.0K | $2M | $15M | $0 | $38.0K | $552.0K | · | · | $1M | $600.0K | · | · | $233.0K | $555.0K | |
| Free Cash Flow | · | $2.61B | · | · | · | $870M | · | · | · | $628M | · | · | · | $407M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $623M | · | · | · | $401M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 8.0% | 15.2% | · | -4.3% | -8.1% | 9.8% | · | -2.0% | 3.1% | 8.7% | · | -4.0% | -0.43% | -1.7% | · | -19.7% | |
| Net Margin | 7.4% | 14.6% | · | -4.6% | -8.0% | 9.0% | · | -2.2% | 2.5% | 8.3% | · | -4.5% | -1.0% | -2.7% | · | -19.7% | |
| Pretax Margin | 7.8% | 15.0% | · | -4.7% | -8.2% | 9.5% | · | -2.2% | 2.8% | 8.3% | · | -4.5% | -0.94% | -2.6% | · | -20.0% | |
| EBITDA Margin | 8.0% | 15.3% | · | -4.3% | -8.1% | 10.0% | · | -2.0% | 3.1% | 9.0% | · | -4.0% | -0.43% | -1.4% | · | -19.7% | |
| ROA | 4.1% | 9.0% | · | -2.7% | -4.0% | 5.4% | · | -1.4% | 1.2% | 4.0% | · | -1.7% | -0.33% | -0.90% | · | -5.2% | |
| ROE | 22.5% | 45.3% | · | -12.6% | -19.9% | 23.3% | · | -5.2% | 5.4% | 18.1% | · | -6.5% | -1.4% | -3.5% | · | -14.6% | |
| ROIC | 14.8% | 32.7% | · | -7.5% | -15.5% | 17.4% | · | -3.4% | 4.4% | 13.9% | · | -4.9% | -0.57% | -2.2% | · | -13.8% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.0 | 1.2 | · | 1.5 | 1.3 | 1.3 | · | 1.4 | |
| Quick Ratio | 0.5 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 31.4 | · | -9.5 | -1.1 | -4.1 | · | -31.4 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 25.7 | 15.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $14.64 | $14.09 | · | $11.52 | $11.21 | $9.96 | · | $9.97 | $7.30 | $7.29 | · | $6.45 | $6.93 | $6.78 | · | $4.60 | |
| Cash Flow / Share | · | $7.94 | · | · | · | $2.87 | · | · | · | $2.16 | · | · | · | $1.91 | · | · | |
| EPS (TTM) | $1.45 | $-0.54 | · | $-1.00 | $-0.69 | $0.40 | · | $-0.08 | $-0.15 | $-0.42 | · | $-1.59 | $-2.21 | $-2.67 | · | $-2.63 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.32B | $13.30B | · | $11.29B | $10.73B | $10.08B | · | $8.22B | $7.23B | $6.54B | · | $5.43B | $4.96B | $4.46B | · | $3.46B | |
| Net Income TTM | $551M | $-39M | · | $-244M | $-161M | $123M | · | $29M | $18M | $-54M | · | $-347M | $-474M | $-571M | · | $-579M | |
| P/E | 19.7 | -21.2 | · | -18.9 | -31.1 | 32.8 | · | -265.1 | -105.5 | -35.4 | · | -3.5 | -3.6 | -2.4 | · | -1.9 | |
| Earnings Yield | 5.1% | -4.7% | · | -5.3% | -3.2% | 3.0% | · | -0.38% | -0.95% | -2.8% | · | -28.5% | -27.4% | -40.8% | · | -52.7% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| Margem Operacional % | -3.4% | 0.62% | -4.0% | · | -29.6% |
| Lucro líquido | $-443M | $25M | $-271M | $-606M | $-573M |
| EPS Diluído | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.4 | 0.3 | 0.4 | · | 0.0 |
| Índice de liquidez corrente | 0.9 | 0.8 | 1.3 | · | 1.2 |
| Índice de Liquidez Seca | 0.6 | 0.6 | 0.8 | · | 0.6 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $1.06B | $950M | $-298M | · | $-208M |
Investidores institucionais (13F) 459 declarantes · $6.2B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 125 (+51 vs trimestre anterior) | 46 (-18 vs trimestre anterior) | 147 (+22 vs trimestre anterior) | 115 (+3 vs trimestre anterior) | +22.8M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $587.153.449 | 20.587.428 | 9,50% | Ações |
| D. E. Shaw & Co., Inc. | $360.595.957 | 12.643.617 | 5,84% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $314.559.172 | 11.029.424 | 5,09% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $301.725.543 | 10.579.437 | 4,88% | Ações |
| VANGUARD GROUP INC | $297.476.962 | 20.701.250 | 4,82% | Ações |
| AMERICAN CENTURY COMPANIES INC | $258.255.502 | 9.055.242 | 4,18% | Ações |
| JANE STREET GROUP, LLC | $181.530.912 | 6.365.039 | 2,94% | Ações |
| Thrive Capital Management, LLC | $180.919.957 | 6.343.617 | 2,93% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $165.994.311 | 5.819.186 | 2,69% | Ações |
| STATE STREET CORP | $165.454.531 | 5.801.351 | 2,68% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $162.917.648 | 5.712.400 | 2,64% | Opção de compra |
| FMR LLC | $142.557.861 | 4.998.523 | 2,31% | Ações |
| CITADEL ADVISORS LLC | $120.626.823 | 4.229.552 | 1,95% | Ações |
| TWO SIGMA INVESTMENTS, LP | $115.097.850 | 4.035.689 | 1,86% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $101.885.043 | 3.571.731 | 1,65% | Ações |
| BIT Capital GmbH | $97.480.134 | 3.417.957 | 1,58% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $93.673.940 | 3.284.500 | 1,52% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $86.282.012 | 3.025.316 | 1,40% | Ações |
| GLYNN CAPITAL MANAGEMENT LLC | $73.462.615 | 2.575.828 | 1,19% | Ações |
| CITADEL ADVISORS LLC | $72.469.320 | 2.541.000 | 1,17% | Opção de compra |
| GOLDMAN SACHS GROUP INC | $65.298.165 | 2.289.557 | 1,06% | Ações |
| NORTHERN TRUST CORP | $63.063.680 | 2.211.209 | 1,02% | Ações |
| WOLVERINE ASSET MANAGEMENT LLC | $61.825.656 | 2.167.800 | 1,00% | Opção de venda |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.458.493 | 2.119.863 | 0,98% | Ações |
| MORGAN STANLEY | $60.299.272 | 2.114.280 | 0,98% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55.351.616 | 1.940.800 | 0,90% | Opção de venda |
| JANE STREET GROUP, LLC | $53.968.396 | 1.892.300 | 0,87% | Opção de compra |
| Nuveen, LLC | $50.501.648 | 1.770.745 | 0,82% | Ações |
| BlackBarn Capital Partners LP | $49.910.000 | 1.750.000 | 0,81% | Opção de venda |
| BNP PARIBAS FINANCIAL MARKETS | $48.660.710 | 1.706.196 | 0,79% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $45.996.029 | 1.612.764 | 0,74% | Ações |
| CITADEL ADVISORS LLC | $44.459.828 | 1.558.900 | 0,72% | Opção de venda |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $41.354.000 | 1.450.000 | 0,67% | Ações |
| BANK OF AMERICA CORP /DE/ | $37.594.294 | 1.318.173 | 0,61% | Ações |
| Assenagon Asset Management S.A. | $35.592.732 | 1.247.992 | 0,58% | Ações |
| TWO SIGMA ADVISERS, LP | $35.534.136 | 2.472.800 | 0,58% | Ações |
| UBS Group AG | $34.596.357 | 1.213.056 | 0,56% | Ações |
| JANE STREET GROUP, LLC | $33.796.200 | 1.185.000 | 0,55% | Opção de venda |
| GROUP ONE TRADING LLC | $32.744.154 | 1.148.112 | 0,53% | Ações |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $31.200.652 | 1.093.992 | 0,51% | Ações |
| Qube Research & Technologies Ltd | $30.913.940 | 1.083.939 | 0,50% | Ações |
| TUDOR INVESTMENT CORP ET AL | $29.055.948 | 1.018.792 | 0,47% | Ações |
| GILDER GAGNON HOWE & CO LLC | $28.576.515 | 1.001.982 | 0,46% | Ações |
| JPMORGAN CHASE & CO | $26.387.407 | 885.558 | 0,43% | Ações |
| FEDERATED HERMES, INC. | $26.096.200 | 915.014 | 0,42% | Ações |
| WELLS FARGO & COMPANY/MN | $23.408.907 | 820.789 | 0,38% | Ações |
| Walleye Capital LLC | $23.243.058 | 814.974 | 0,38% | Ações |
| Point72 Asset Management, L.P. | $22.809.212 | 799.762 | 0,37% | Ações |
| Walleye Trading LLC | $22.744.700 | 797.500 | 0,37% | Opção de compra |
| Bank of New York Mellon Corp | $22.032.138 | 772.515 | 0,36% | Ações |
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Claremount TW, L.P., Claremount V Associates, L.P., Claremount VI Associates, L.P., Claremount VII Associates, L.P., Joshua Kushner, Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., Thrive Capital Partners V, L.P., Thrive Capital Partners VI Growth, L.P., Thrive Capital Partners VII Growth, L.P., Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII GP, LLC, Thrive Partners VII Growth GP, LLC | 18 de Setembro de 2026 | 12,10% | Emenda | · | SEC |
| Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 declarações | 13 de Novembro de 2024 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 23 insiders · 12 diretores · 12 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Mark T Bertolini | Chief Executive Officer | 30 de Junho de 2026 S | 7.751.570 | 1 | 8 | $-58.759.399 |
| Richard Scott Blackley | Chief Financial Officer | 3 de Setembro de 2026 S | 1.046.108 | 0 | 9 | $-7.941.907 |
| Janet Liang | President, Oscar Insurance | 3 de Setembro de 2026 S | 248.697 | 0 | 5 | $-821.072 |
| Steven Wolin | Chief Operating Officer | 1 de Dezembro de 2024 M | 102.598 | 0 | 0 | $0 |
| Meghan V. Joyce | Chief Operating Officer | 1 de Março de 2022 M | 43.070 | 0 | 0 | $0 |
| Joshua Kushner | Co-Founder and Vice Chairman | 18 de Setembro de 2026 J | 0 | 0 | 0 | $0 |
| Victoria Baltrus | Chief Accounting Officer | 3 de Setembro de 2026 S | 213.631 | 0 | 5 | $-194.480 |
| Adam Mcananey | Chief Legal Officer | 3 de Setembro de 2026 S | 209.004 | 0 | 5 | $-783.513 |
| Alessandrea C. Quane | EVP, Chief Insurance Officer | 5 de Dezembro de 2024 M | 430.216 | 0 | 0 | $0 |
| Ranmali Bopitiya | EVP & Chief Legal Officer | 1 de Dezembro de 2024 M | 241.488 | 0 | 0 | $0 |
| Dennis Weaver | Chief Clinical Officer | 1 de Dezembro de 2022 M | 27.110 | 0 | 0 | $0 |
| Joel Klein | Chief Policy & Strat. Officer | 18 de Agosto de 2021 M | 17 | 0 | 0 | $0 |
| Vanessa Ames Wittman | Conselheiro | 18 de Setembro de 2026 S | 112.121 | 0 | 1 | $-806.000 |
| Mario Schlosser | Conselheiro | 3 de Setembro de 2026 S | 449.444 | 0 | 29 | $-68.790.950 |
| William Gassen | Conselheiro | 9 de Julho de 2026 A | 82.840 | 0 | 0 | $0 |
| David Plouffe | Conselheiro | 9 de Julho de 2026 A | 137.121 | 0 | 0 | $0 |
| Sid Sankaran | Conselheiro | 9 de Julho de 2026 A | 22.609 | 0 | 0 | $0 |
| Laura W Lang | Conselheiro | 4 de Junho de 2026 A | 82.840 | 0 | 0 | $0 |
| Jeffery H Boyd | Conselheiro | 9 de Abril de 2026 A | 705.673 | 0 | 0 | $0 |
| Elbert O. Robinson Jr. | Conselheiro | 12 de Maio de 2025 S | 64.512 | 0 | 0 | $0 |
| Jr Charles E Phillips | Conselheiro | 14 de Outubro de 2022 A | 85.787 | 0 | 0 | $0 |
| Teri List-Stoll | Conselheiro | 5 de Março de 2021 A | 50.000 | 0 | 0 | $0 |
| Ari Fischel | · | 5 de Março de 2021 A | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 46 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| ABLS · Abacus FCF ETF Trust | 5,83% | 867 NS | 31 de Julho de 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,95% | 188.213 SH | 2 de Outubro de 2026 | Diário |
| RNIN · EA Series Trust | 1,20% | 70.047 NS | 31 de Julho de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,74% | 307.696 NS | 31 de Julho de 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,60% | 69.666 NS | 31 de Julho de 2026 | N-PORT |
| IWO · iShares Trust | 0,52% | 2.269.828 SH | 11 de Setembro de 2026 | Diário |
| JSMD · Janus Detroit Street Trust | 0,51% | 171.181 NS | 31 de Julho de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,40% | 258.034 SH | 19 de Agosto de 2026 | Diário |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 48.469 SH | 2 de Outubro de 2026 | Diário |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,35% | 152.933 NS | 31 de Julho de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,31% | 8.798 NS | 31 de Julho de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 61.099 NS | 31 de Julho de 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0,27% | 19.102 NS | 31 de Julho de 2026 | N-PORT |
| IWM · iShares Trust | 0,26% | 6.175.602 SH | 11 de Setembro de 2026 | Diário |
| FBUF · Fidelity Greenwood Street Trust | 0,25% | 1.889 NS | 31 de Julho de 2026 | N-PORT |
| ISCG · iShares Trust | 0,24% | 71.367 SH | 11 de Setembro de 2026 | Diário |
| RSSL · Global X Funds | 0,24% | 115.406 NS | 31 de Julho de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,21% | 1.387.125 SH | 19 de Agosto de 2026 | Diário |
| FHEQ · Fidelity Greenwood Street Trust | 0,21% | 61.010 NS | 31 de Julho de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,19% | 3.171.535 SH | 19 de Agosto de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,16% | 805.292 NS | 31 de Julho de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,16% | 145.781 SH | 2 de Outubro de 2026 | Diário |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 27.872 NS | 31 de Julho de 2026 | N-PORT |
| ESML · iShares Trust | 0,11% | 96.895 SH | 11 de Setembro de 2026 | Diário |
| FNCL · FIDELITY COVINGTON TRUST | 0,08% | 61.975 NS | 31 de Julho de 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,08% | 5.488.922 SH | 19 de Agosto de 2026 | Diário |
| VFH · VANGUARD WORLD FUND | 0,08% | 384.466 SH | 19 de Agosto de 2026 | Diário |
| WSML · iShares Trust | 0,07% | 14.630 SH | 11 de Setembro de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,07% | 2.534.194 SH | 19 de Agosto de 2026 | Diário |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 12.495 SH | 2 de Outubro de 2026 | Diário |
| DFSU · Dimensional ETF Trust | 0,03% | 20.892 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 21.472 NS | 31 de Julho de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 286.808 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 12.166 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 50.403 NS | 31 de Julho de 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 64.590 SH | 11 de Setembro de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 7.601.113 SH | 19 de Agosto de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 194.738 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19.808 SH | 19 de Agosto de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,01% | 66.708 NS | 31 de Julho de 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,01% | 53.203 SH | 19 de Agosto de 2026 | Diário |
| ITOT · iShares Trust | 0,01% | 287.602 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,00% | 472 NS | 31 de Julho de 2026 | N-PORT |
| IAK · iShares Trust | · | 117.671 SH | 11 de Setembro de 2026 | Diário |
| ISCB · iShares Trust | · | 10.063 SH | 11 de Setembro de 2026 | Diário |
| SMLF · iShares Trust | · | 286.871 SH | 11 de Setembro de 2026 | Diário |
OSCR Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
10 analistas · 2026-10-03Alvo médio $35.40 +14,4%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| OSCR | · | -8.5 | 27.5% | -3.8% | -44.5% | · |
| AFL | $57.20B | 16.2 | -9.3% | 21.2% | 12.9% | · |
| PRU | · | · | · | · | · | · |
| PFG | $19.18B | 16.8 | -3.1% | 7.6% | 10.3% | · |
| UNM | · | · | · | · | · | · |
| GL | $12.90B | 9.9 | 3.7% | 19.4% | 20.4% | · |
| PRI | $8.22B | 11.3 | 6.6% | 22.8% | 31.9% | · |
| LNC | $8.46B | 7.6 | -1.2% | 6.5% | 12.3% | · |
| CNO | $4.01B | 18.5 | 0.85% | 5.1% | 8.9% | · |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.